Skip to content

Arvinas, Inc.

ARVN· NasdaqCore metricsCIK 1655759

Pharmaceutical preparations552 peers

Last sale
Nov 2, 2026 · -4.01%
Market cap
$493.43M
65.49M shares
Filings
605
$500.00K
Q3 2026−0.3% FY25 yoy
-$53.90M
Q3 2026N/M FY25 yoy
-$59.10M
Q3 2026N/M FY25 yoy
-$129.20M
Q3 2026derivedN/M FY25 yoy
-$0.82
Q3 2026N/M FY25 yoy
$88.00M
Q3 2026+42.2% FY25 yoy
$493.43M
—
1.8×
1.0×
-32.39%
—

Twelve months to Sep 30, 2026 · derived

Price

$7.5422.56%$2.20past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$262.60MFY 2025
$263.40M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$262,600,000reported
FY 20242024-12-31$263,400,000reported
FY 20232023-12-31$78,500,000reported
FY 20222022-12-31$131,400,000reported
FY 20212021-12-31$46,700,000 revisedreported
FY 20202020-12-31$21,800,000 revisedreported
FY 20192019-12-31$18,300,000 revisedreported
FY 20182018-12-31$14,300,000reported
FY 20172017-12-31$7,578,876reported

Capital returns

Dividends and buybacks · FY2023 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$91.90M$91.90M—63.96M sh−7.0%—
FY2024—$0.00$0.00—68.77M sh+1.0%—
FY2023—$0.00$0.00—68.08M sh+27.8%—

Pharmaceutical preparations

Arvinas, Inc. is the 75th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Arvinas, Inc. · CIK 1655759 · Engraved from SEC EDGAR